Sven Schippling is currently Deputy Head of the Department of Neuroimmunology and Clinical Multiple Sclerosis Research (NIMS) at the University Hospital Zurich, Switzerland. He is also the Co-Director of the Clinical Research Priority Program MS (CRPPMS) and Consultant Neurologist at the Department of Neurology at University Hospital Zurich. He is a Senior Group Leader at the Neuroscience Center Zurich of the Federal Technical Highschool Zurich and the University of Zurich. Prior to this, he was Head of the first MS Day Clinic in Germany at the University Medical Center of Hamburg University, Germany. From 2005 to 2006 he was a Postdoctoral Research Fellow at the Institute of Neurology, University College London, UK and the National Hospital for Neurology and Neurosurgery, London. Dr. Schippling’s areas of special interest are clinical neuroimmunology, mainly within the fields of multiple sclerosis (MS) and neuromyelitis optica. His research focuses include multimodal imaging methods in MS, such as magnetic resonance imaging and optical coherence tomography, transcranial magnetic stimulation and clinical trials including stem cell therapies in MS (haematopoietic and mesenchymal). Dr. Schippling is also a member of the steering group for the ‘MS in the 21st Century’ initiative, the multinational OCTIMS and BENEFIT11 trials and has authored numerous peer-reviewed publications.